Carboplatin beyond 4 cycles during therapy with carboplatin, pemetrexed, and pembrolizumab for advanced non-small cell lung cancer (NSCLC). N = 4090 Percent of Population Completed HRBC appt N = 122 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results